This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Healthcare LLC. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Innovator Spotlight: Dennis Doleschel from Aachen, DE
Introduction:
Dennis Doleschel, a talented inventor based in Aachen, DE, has made significant contributions to the field of pharmaceutical compositions and treatments for hyperproliferative disorders.
Latest Patents:
Dennis holds two groundbreaking patents, the most recent being the "Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer." This innovative pharmaceutical composition aims to treat, prevent, or manage diseases like cancer in humans and other mammals by combining regorafenib with PD-1/PD-L1(2) inhibitors.
Career Highlights:
With an impressive background, Dennis has worked with renowned companies such as Bayer Healthcare LLC and Bayer Aktiengesellschaft. His dedication to research and development in the pharmaceutical industry has led to the creation of cutting-edge solutions for challenging medical conditions.
Collaborations:
Throughout his career, Dennis has collaborated closely with accomplished professionals in the field, including Sabine Hoff and Lars Rose. These collaborations have played a pivotal role in advancing medical treatments and improving patient outcomes.
Conclusion:
In conclusion, Dennis Doleschel's inventive spirit and commitment to innovation have paved the way for groundbreaking advancements in the pharmaceutical industry. His contributions continue to impact the lives of individuals affected by hyperproliferative disorders, showcasing his talent as a visionary inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile